This journal focuses on pulmonary hypertension (PH) and related conditions, including pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), and pulmonary hypertension associated with chronic lung disease (PH-CLD). Research covers diagnostic tools, biomarkers, treatment strategies, and patient outcomes. Specific areas of investigation include right ventricular dysfunction, ventilatory inefficiency, and the impact of comorbidities like diabetes and kidney disease. The journal also explores novel therapeutic agents and the management of specific patient populations, such as those with methamphetamine-associated PAH or pediatric PH.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Pulmonary and Respiratory MedicineQ2
Subject Classification
Web of Science Categories
Cardiac & Cardiovascular SystemRespiratory System
Scopus Categories
Pulmonary and Respiratory Medicine
Research Topics (OpenAlex)
Pulmonary Hypertension Research and TreatmentsCardiovascular Function and Risk FactorsCardiovascular Issues in PregnancyHeart Failure Treatment and ManagementVascular Anomalies and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisCongenital Heart Disease StudiesChronic Obstructive Pulmonary Disease (COPD) ResearchVenous Thromboembolism Diagnosis and ManagementLiver Disease and Transplantation